Liberum Capital Reaffirms Buy Rating for Melrose Industries (MRO)
Melrose Industries (LON:MRO)‘s stock had its “buy” rating restated by analysts at Liberum Capital in a research note issued to investors on Friday. They currently have a GBX 260 ($3.53) price objective on the stock. Liberum Capital’s price objective would suggest a potential upside of 14.29% from the company’s previous close.
A number of other brokerages have also recently commented on MRO. Numis Securities restated a “buy” rating and issued a GBX 250 ($3.39) price target on shares of Melrose Industries in a research report on Monday, December 4th. JPMorgan Chase & Co. restated an “overweight” rating and issued a GBX 250 ($3.39) price target on shares of Melrose Industries in a research report on Friday, January 5th. Deutsche Bank restated a “hold” rating and issued a GBX 220 ($2.98) price target on shares of Melrose Industries in a research report on Friday, October 13th. Peel Hunt restated a “buy” rating and issued a GBX 240 ($3.25) price target on shares of Melrose Industries in a research report on Thursday, January 4th. Finally, Royal Bank of Canada reduced their price target on Melrose Industries from GBX 240 ($3.25) to GBX 235 ($3.19) and set an “outperform” rating for the company in a research report on Friday, November 24th. Two investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of GBX 258.64 ($3.51).
Shares of Melrose Industries (MRO) traded up GBX 12.50 ($0.17) on Friday, reaching GBX 227.50 ($3.09). The company’s stock had a trading volume of 61,719,182 shares, compared to its average volume of 5,630,000. Melrose Industries has a fifty-two week low of GBX 2.13 ($0.03) and a fifty-two week high of GBX 261.90 ($3.55).
Receive News & Stock Ratings for Melrose Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Melrose Industries and related stocks with our FREE daily email newsletter.